Impurities of N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) were detected in the active substance Losartanum kalicum from the manufacturer Zhejiang Huahai Pharmaceutical Co. Ltd. Potential effects: possible carcinogenic effects and health risks with long-term use.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use or dispense the withdrawn losartan-containing products from the indicated manufacturer; patients should contact their doctor or pharmacist to determine further treatment.
The Chief Pharmaceutical Inspector issued a decision on the immediate withdrawal from the market of medicinal products containing the active substance losartan potassium with NDMA and NDEA impurities ...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related